Shu-Yi Ho

4.0k total citations
7 papers, 68 citations indexed

About

Shu-Yi Ho is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Shu-Yi Ho has authored 7 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Genetics. Recurrent topics in Shu-Yi Ho's work include RNA modifications and cancer (2 papers), Virus-based gene therapy research (2 papers) and Cell death mechanisms and regulation (2 papers). Shu-Yi Ho is often cited by papers focused on RNA modifications and cancer (2 papers), Virus-based gene therapy research (2 papers) and Cell death mechanisms and regulation (2 papers). Shu-Yi Ho collaborates with scholars based in Taiwan and United States. Shu-Yi Ho's co-authors include Kuang‐Wen Liao, Nu‐Man Tsai, Yu‐Ling Lin, Hsin-Yi Wu, Chia‐Hung Chen, Yi‐Han Chiu, Ming-Hua Hsu, Cheng‐Hsun Chuang, Chia‐Hung Chen and Yi‐Hsuan Tsai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Agricultural and Food Chemistry and Oncotarget.

In The Last Decade

Shu-Yi Ho

7 papers receiving 67 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shu-Yi Ho Taiwan	5	29	17	11	8	7	7	68
Farima Zahedi Netherlands	7	75 2.6×	27 1.6×	18 1.6×	13 1.6×	5 0.7×	11	135
Hongsheng Bi China	7	48 1.7×	22 1.3×	3 0.3×	7 0.9×	6 0.9×	18	166
Yunshan Zhu China	5	84 2.9×	31 1.8×	7 0.6×	9 1.1×	7 1.0×	10	180
Myriam Boyer-Clavel France	4	38 1.3×	12 0.7×	9 0.8×	7 0.9×	3 0.4×	5	95
Hyung Seok Jang South Korea	7	30 1.0×	13 0.8×	4 0.4×	6 0.8×	3 0.4×	12	82
Yuzu Kubota United States	4	58 2.0×	25 1.5×	25 2.3×	11 1.4×	4 0.6×	4	130
Lila Kim South Korea	8	70 2.4×	17 1.0×	7 0.6×	5 0.6×	5 0.7×	16	121
Signe Bek Sørensen Denmark	5	41 1.4×	30 1.8×	7 0.6×	7 0.9×	3 0.4×	8	128
Katrien Vanderheyden Belgium	6	37 1.3×	8 0.5×	7 0.6×	10 1.3×	3 0.4×	7	78

Countries citing papers authored by Shu-Yi Ho

Since Specialization

Citations

This map shows the geographic impact of Shu-Yi Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Yi Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Yi Ho more than expected).

Fields of papers citing papers by Shu-Yi Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Yi Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Yi Ho. The network helps show where Shu-Yi Ho may publish in the future.

Co-authorship network of co-authors of Shu-Yi Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Yi Ho. A scholar is included among the top collaborators of Shu-Yi Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Yi Ho. Shu-Yi Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ho, Shu-Yi, et al.. (2020). Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules. Journal of Nanobiotechnology. 18(1). 58–58. 12 indexed citations

2.

Ho, Shu-Yi, et al.. (2018). Development of a computational promoter with highly efficient expression in tumors. BMC Cancer. 18(1). 480–480. 3 indexed citations

3.

Ho, Shu-Yi, Yu‐Ling Lin, Chia‐Hung Chen, et al.. (2018). Helicobacter pylori -derived heat shock protein 60 increases the induction of regulatory T-cells associated with persistent infection. Microbial Pathogenesis. 119. 152–161. 11 indexed citations

4.

Chen, Chi‐Long, Kuang‐Wen Liao, Shu-Yi Ho, et al.. (2017). cIAP-2 Expression Increases in Elderly Patients with Squamous Cell Carcinoma of the Head and Neck. International journal of gerontology. 11(1). 22–26. 2 indexed citations

5.

Lin, Yu‐Ling, Shu-Yi Ho, Yi‐Hsuan Tsai, et al.. (2016). The inhibitory effect of 7,7″-dimethoxyagastisflavone on the metastasis of melanoma cells via the suppression of F-actin polymerization. Oncotarget. 8(36). 60046–60059. 9 indexed citations

6.

Lin, Yu‐Ling, Nu‐Man Tsai, Shu-Yi Ho, et al.. (2016). In vivo amelioration of endogenous antitumor autoantibodies via low-dose P₄N through the LTA4H/activin A/BAFF pathway. Proceedings of the National Academy of Sciences. 113(48). E7798–E7807. 10 indexed citations

7.

Lin, Yu‐Ling, Nu‐Man Tsai, Hsin-Yi Wu, et al.. (2012). Inhibitory Effects of Chloroform Extracts Derived from Corbicula fluminea on the Release of Pro-inflammatory Cytokines. Journal of Agricultural and Food Chemistry. 60(16). 4076–4082. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact